Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

GeneDx Holdings Corp. - Class A Common Stock (NQ: WGS )

92.08 +4.91 (+5.63%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 521,719
Open 92.01
Bid (Size) 90.00 (1)
Ask (Size) 104.88 (9)
Prev. Close 87.17
Today's Range 87.25 - 94.99
52wk Range 7.720 - 115.60
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
SPY Trying To Find A Floor At The 200 SMA; One New Swing
In this video lesson I review the day-one of a new rally attempt in the overall market, discuss my new swing trade in a cyber-security leader, and review my tier-one long-term portfolio purchases in my... 
Via Talk Markets
Topics Stocks / Equities
GeneDx Expands Commercial Footprint for Exome and Genome Testing with Cerebral Palsy as a New Indication
From GeneDx
Via Business Wire

Performance

YTD
+15.63%
+15.63%
1 Month
+35.11%
+35.11%
3 Month
+24.72%
+24.72%
6 Month
+161.15%
+161.15%
1 Year
+803.19%
+803.19%

More News

Read More
Powerful UnR Session As All Four Market Indices Lockstep Rally Into The Close; Bear Trap Set?
Via Talk Markets
Topics Stocks / Equities
Landmark Seqfirst-neo Study Showcases the Significant Impact of Genomic Testing in the NICU, Revealing Gaps in Current Protocols
From GeneDx
Via Business Wire
Top Biotech GeneDx Catapults 42% After Obliterating Earnings Forecasts
Via Investor's Business Daily
Crude Oil Gains 1.5%; Fluor Shares Plunge Following Downbeat Earnings
Via Benzinga
Exposures Fossil Fuels
Watsco Posts Upbeat Results, Joins GeneDx, Intel And Other Big Stocks Moving Higher On Tuesday
Via Benzinga
US, Russia Begin Ukrainian Peace Talks, Intel Shares Surge: What's Driving Markets Tuesday?
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
GeneDx Reports Fourth Quarter and Full Year 2024 Financial Results and Issues Guidance for Full Year 2025
From GeneDx
Via Business Wire
WeRide, CRISPR And GeneDx Are Among Top 10 Mid-Cap Gainers Last Week (Feb 10-Feb 14): Are The Others In Your Portfolio?
Via Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
GeneDx Announces ultraRapid Whole Genome Sequencing, Delivering Actionable Results in as soon as 48 Hours to Inform Care for Critically Ill NICU and PICU Patients
From GeneDx
Via Business Wire
Earnings Scheduled For February 18, 2025
Via Benzinga
GeneDx to Participate in 45th Annual TD Cowen Health Care Conference
From GeneDx
Via Business Wire
GeneDx Integrates with Epic, Enabling Broad Adoption of Genome and Exome Sequencing for Health Systems to Inform Patient Diagnosis and Accelerate Treatment
From GeneDx
Via Business Wire
GeneDx to Report Fourth Quarter and Full Year 2024 Financial Results on Tuesday, February 18, 2025
From GeneDx
Via Business Wire
GeneDx: Even After Up 2,700% in 2024, Upside Is Still in Play
Via MarketBeat
GeneDx Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
From GeneDx
Via Business Wire
Stocks Moving Lower Despite Encouraging Inflation Data
Via Talk Markets
Topics Economy Stocks / Equities
Exposures Interest Rates
GeneDx Announces Preliminary 2024 Financial Results
From GeneDx
Via Business Wire
GeneDx Introduces New Telehealth Pathway to Expand Access to Exome Testing for Parents Seeking Answers
From GeneDx
Via Business Wire
I’m Not Worried About This Pullback
Via Talk Markets
Topics Cryptocurrencies Stocks / Equities
GeneDx Continues its Leadership in Genomics Research, Refining Gene-Disease Relationships and Impacting Results of >22,000 Patients
From GeneDx
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.